BioSpace News Archive

Valbiotis Presents Additional Positive Results from the HEART Clinical Study on TOTUM•070 for Hypercholesterolemia

Valbiotis, a Research and Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, presents additional positive results from the Phase II HEART clinical study with TOTUM•070 for hypercholesterolemia.

October 3, 2022
·
8 min read
Policy

Poxel Announces PXL770 Granted Orphan Drug Designation from the U.S. FDA for Autosomal-Dominant Polycystic Kidney Disease (ADPKD)

POXEL SA announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to PXL770 for the treatment of patients with autosomal-dominant polycystic kidney disease.

October 3, 2022
·
5 min read
Business

Vico Therapeutics Appoints Scott Schobel, MD as Chief Medical Officer

Vico Therapeutics B.V., a neurology-focused genetic medicine company, announced the appointment of Scott Schobel, MD as chief medical officer.

October 3, 2022
·
3 min read
Pharm Country

Lumanity Expands Launch Excellence Capabilities

Lumanity announced that it has expanded its pharmaceutical product launch capabilities, creating a technology-enabled, end-to-end launch excellence service offering.

October 3, 2022
·
2 min read
Deals

PACT Pharma Announces Agreement to Sell Select Assets to AmplifyBio

PACT Pharma, Inc. announced that it has entered into an agreement to sell select assets to AmplifyBio, a contract research organization focused on accelerating innovation across pharmaceutical modalities.

October 3, 2022
·
2 min read
Deals

Amplifybio Acquires PACT Pharma Assets to Enhance Cell and Gene Therapy Characterization Capabilities

AmplifyBio, a contract research organization focused on accelerating innovation across pharmaceutical modalities; announced the acquisition of select assets from PACT Pharma, Inc., a privately held biopharmaceutical company developing neoantigen-specific T cell receptor cell therapies.

October 3, 2022
·
3 min read
Drug Development

Seneca Therapeutics Receives FDA Clearance to Begin SVV-001 Phase I/II Clinical Study

Seneca Therapeutics, Inc. announced it had received FDA clearance to begin a Phase I/II clinical study utilizing Seneca Valley Virus in combination with a checkpoint inhibitor.

October 3, 2022
·
1 min read
Deals

Incyte Announces Agreement to Acquire Medicxi-backed Villaris Therapeutics and Auremolimab (VM6), an Anti-IL-15Rβ Monoclonal Antibody

Incyte announced that the Company has entered into an agreement to acquire Villaris Therapeutics, an asset-centric biopharmaceutical company seeded by Medicxi and focused on the development of novel antibody therapeutics for vitiligo.

October 3, 2022
·
7 min read
Biotech Beach

Modular Medical Provides Product Update - October 03, 2022

Modular Medical Inc., a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, provided an update on its insulin pump product.

October 3, 2022
·
3 min read
BioMidwest

All 14 OneOncology Partner Practices Apply to Participate in EOM

OneOncology, the national platform for independent oncology practices, announced that all 14 of its partner practices have applied to participate in Medicare’s Enhancing Oncology Model, the agency’s value-based care model for oncology.

October 3, 2022
·
3 min read